BridgeBio Oncology Therapeutics, Inc. · NASDAQ:BBOT

Cobo Marc sold 78 BridgeBio Oncology Therapeutics, Inc. shares (Form 4)

Traded Nov 13, 2026 · Filed Nov 17, 2026

On Nov 13, 2026, Cobo Marc (Principal Accounting Officer) sold 78 BridgeBio Oncology Therapeutics, Inc. shares at US$2.37 for US$185 under a trading plan, leaving 13,734 shares. Filed Nov 17, 2026 (Form 4).

Sold
78 shares
Price
US$2.37
Value
US$185
Holding after
13,734 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Principal Accounting Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Nov 13, 2026Common StockSale78US$2.3713,734Direct

Source

Download original · View original at SEC

Related